The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial
Open accessAbstract
BACKGROUND: Suicidal thoughts and behaviours during antidepressant treatment, especially during the first weeks of treatment, have prompted warnings by regulatory bodies. The aim of the present study is to investigate the course and predictors of emergence and worsening of suicidal ideation during tricyclic antidepressant and serotonin reuptake inhibitor treatment. METHODS: In a multicentre part-randomised open-label study, 811 adult patients with moderate to severe unipolar depression were allocated to flexible dosage of escitalopram or nortriptyline for 12 weeks. The suicidality items of three standard measures were integrated in a suicidal ideation score. Increases in this score were classified as treatment emergent suicidal ideation (TESI) or treatment worsening suicidal ideation (TWOSI) according to the absence or presence of suicidal ideation at baseline. RESULTS: Suicidal ideation decreased during antidepressant treatment. Rates of TESI and TWOSI peaked in the fifth week. Severity of depression predicted TESI and TWOSI. In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively. Retirement and history of suicide attempts predicted TWOSI. CONCLUSION: Increases in suicidal ideation were associated with depression severity and decreased during antidepressant treatment. In men, treatment with escitalopram is associated with lower risk of suicidal ideation compared to nortriptyline. Clinicians should remain alert to suicidal ideation beyond the initial weeks of antidepressant treatment. TRIAL REGISTRATION: EudraCT (No.2004-001723-38) and ISRCTN (No. 03693000).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“SSRIs target serotonin, and appeared more effective than noradrenergic drugs for suicidal ideation.(59, 61)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [61]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More promisingly, antidepressants reduced suicidal ideation in 9/12 studies that reported effects on suicidal ideation.(55, 57, 59–65)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilevel and Longitudinal Modeling Using Stata
(2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00588_16.x · Cited by 4,236 · cited 9×
“Treatment worsening suicidal ideation (TWOSI) was defined as an increase of suicidal ideation of at least 0.5 SD above the individual's baseline score at any point during the study in individuals with significant suicidal ideation at baseline.”
Influential(2000) · Cited by 4,106
Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Davis, S. M., Harrison, W. M., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1445 · Cited by 702 · cited 1×
“As there are controversies about gender differences in antidepressant treatment response, it is warranted to investigate moderation of suicidal ideation during such treatment by gender [16].”
Family genetic studies, suicide, and suicidal behavior
Brent, D. A., & Mann, J. J. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30042 · Cited by 617 · cited 1×
“Another limitation is that our results could not be generalised to other forms of suicidal behaviours such as suicide attempts and suicide completion as the relationship between these phenomena has been shown to be imperfect [45].”
Gauderman, W. J., Morrison, J., & Morrison, W. M. (2006) · Medical Entomology and Zoology · Cited by 595
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Effect of Age at Onset on the Course of Major Depressive Disorder
Zisook, S., Lesser, I., Stewart, J. W., Wisniewski, S. R., Balasubramani, G. K., Fava, M., Gilmer, W. S., Dresselhaus, T. R., Thase, M. E., Nierenberg, A. A., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101757 · Cited by 548 · cited 1×
“This is consistent with several other studies [9,11,13,40].”
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510 · cited 12×
“In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively.”
InfluentialBech, P., Gram, L. F., Dein, E., Jacobsen, O., Vitger, J., & Bolwig, T. G. (1975) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1975.tb00002.x · Cited by 489
Gunnell, D., Saperia, J., & Ashby, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.385 · Cited by 387 · cited 3×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18,27-30], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Cited by
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20060864 · Cited by 655
Britton, W. B., Lepp, N. E., Niles, H. F., Rocha, T., Fisher, N. E., & Gold, J. S. (2014) · Journal of School Psychology · doi:10.1016/j.jsp.2014.03.002 · Cited by 249
Is it valid to measure suicidal ideation by depression rating scales?
Desseilles, M., Perroud, N., Guillaume, S., Jaussent, I., Genty, C., Malafosse, A., & Courtet, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.013 · Cited by 208
“A couple of recent pharmacogenetic studies used the ‘suicide’ item of Hamilton's, Beck's or Montgomery–Asberg's depressive scale in order to assess the suicidal ideations associated with antidepressant treatment in the context of clinical trials (Perroud, 2011; Perroud et al., 2009a, 2009b, 2010).”
ResultSelf-citationGender differences in antidepressant drug response
Keers, R., & Aitchison, K. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.496448 · Cited by 185
“Specifically, men treated with nortriptyline were more likely to suffer from increasing suicidal ideation during treatment (Perroud et al., 2009).”
BackgroundSelf-citationUher, R., Mors, O., Rietschel, M., Rajewska-Rager, A., Petrovic, A., Zobel, A., Henigsberg, N., Mendlewicz, J., Aitchison, K., Farmer, A., et al. (2011) · Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06419 · Cited by 139
Self-citation
Metadata
- Authors
- Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., Szczepankiewicz, A., Jorgensen, L., Strohmaier, J., Zobel, A., Giovannini, C., Elkin, A., Gunasinghe, C., Gray, J., Campbell, D., Gupta, B., Farmer, A. E., McGuffin, P., & Aitchison, K. J.
- Affiliations
- King's College London (GB)
- Central Institute of Mental Health (DE)
- Aarhus University Hospital (DK)
- University of Zagreb (HR)
- Poznan University of Medical Sciences (PL)
- University of Bonn (DE)
- Université Libre de Bruxelles (BE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- Corresponding author
- Perroud, Nader
- ORCID
- Venue
- BMC Medicine
- Published
- 2009-10-15
- Volume
- 7
- Issue
- 1
- Pages
- 60-60
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC2768737
- OpenAlex
- W2159946604
- Cited by
- 57
- References
- 41
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 3 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 9 · 2013: 2 · 2012: 5
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (118605)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- suicidal ideation, depression, escitalopram, nortriptyline, antidepressant treatment, tricyclic antidepressants, selective serotonin reuptake inhibitors, depression severity, suicide attempts, sex differences
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Tricyclic, Depressive Disorder, Female, Humans, Male, Middle Aged, Nortriptyline, Personality Inventory, Suicide, Citalopram, Selective Serotonin Reuptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial. https://app.cochat.ai/papers/10.1186/1741-7015-7-60
- The paper
- Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., Szczepankiewicz, A., Jorgensen, L., Strohmaier, J., Zobel, A., Giovannini, C., Elkin, A., Gunasinghe, C., Gray, J., Campbell, D., . . . Aitchison, K. J. (2009). Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial. BMC Medicine. https://doi.org/10.1186/1741-7015-7-60
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.